Management of febrile neutropenia: ESMO clinical recommendations.
Marti
F Marti
FM
Department of Medical Oncology, University Hospital Birmingham, NHS Foundation Trust, Birmingham, UK.
Cullen
M H
MH
Roila
F
F
D000970:Antineoplastic Agents / Q000009:adverse effects; D019468:Disease Management; D005060:Europe / Q000453:epidemiology; D005334:Fever / Q000139:chemically induced / Q000628:therapy*; D006287:Health Planning Guidelines; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy*; D012955:Societies, Medical / Q000592:standards*
D000970:Antineoplastic Agents